Like this Product? Add to Product Favorites
Unit Price: FOB,CIF | Get Latest Price
Model No.: 0.25ml/vial and 0.25ml/syringe
Min. Order: 5000 Others
Payment Type: L/C,T/T
Transportation: Air
Productivity: 20 million human doses
Place of Origin: China
Brand: WANXIN
Supply Ability: 20 million human doses
Influenza Vaccine (Split Virion), Inactivated
Apply the most advanced technology in the world to production of influenza vaccine and arrange vaccine production and quality control according to current influenza virus recommended by WHO. Each quality index of the influenza vaccine is excellent.
[Eligibles]
Susceptible individuals and persons liable to be afflicted with the associated complications, such as children, elderly persons and individuals in the epidemic area.
[Function and use]
The product can induce immunity against influenza virus in recipients following immunization. It is used to prevent the infections of the prevalent strains of influenza viruses.
[Specifications]
0.25 ml or 0.5 ml per container. 0.25 ml per single human dose (used for children aged between 6 months and 3 years) .shall contain 7.5μg of influenza haemagglutinin of each influenza virus strain. 0.5 ml per single human dose (used for adult and children aged above 3 years) shall contain 15μg of influenza haemagglutinin of each influenza virus strain.
[Advantages]
(1) Apply centrifugal purification and column chromatography purification technology to purifying virus and obtained the patent certificate of making use of Sepharose4FF column chromatography technology for vaccine manufacture. The product quality index is excellent and the purity is high;
(2) High-level GMT of conversion rate of serum antibody with safety and reliable effect for prevention;
(3) Various Specifications:
1) Vial type for adult: 0.5ml/vial for people above 3 years old;
Vial type for children:0.25ml/vial for children from 6 to 35 months old;
2) Syringe type for adult: 0.5ml/syringe for people above 3 years old;
Syringe type for children:0.25ml/syringe for children from 6 to 35 months old;
(4) Exclusively apply two dosage forms of pre-filled syringe from American BD Company and vial pack for security and convenience;
(5) Rated as National New and Key Product by the Ministry of Science and Technology, Ministry of Foreign Trade and Economic Cooperation, State General Administration of Supervision, Inspection and Quarantine, State Environmental Protection Administration of China; rated as Excellent Technology Product by China Association for Science and Technology; award the Honor of Science and Technology Progress by Changchun City Administration of Science and Technology;
(6) Successfully registered in over 20 countries and export to dozens of countries for consecutive years.
Changchun Changsheng Life Sciences Ltd.
Ms. Gao
Manufacturer , Trade Company
Rabies Vaccine , Varicella Vaccine , Influenza Vaccine , Hepatitis A Vaccine , ACYW135 Meningococcal Polysaccharide Vaccine , Bulk of Rabies Vaccine
>1000
66,480,000RMB
1992
Manufacturer , Trade Company
No.1615 Yueda Road